Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2018 pay jumps 389% to $7.3M
Kiniksa Pharmaceuticals, Ltd. reports 2018 executive compensation
By ExecPay News
Published: April 17, 2019
Kiniksa Pharmaceuticals, Ltd. reported fiscal year 2018 executive compensation information on April 17, 2019.
In 2018, three executives at Kiniksa Pharmaceuticals, Ltd. received on average a compensation package of $4.2M, a 319% increase compared to previous year.
Average pay of disclosed executives at Kiniksa Pharmaceuticals, Ltd.
Sanj K. Patel, Chief Executive Officer, received $7.3M in total, which increased by 389% compared to 2017. 80% of Patel's compensation, or $5.8M, was in option awards. Patel also received $743K in non-equity incentive plan, $740K in salary, as well as $11K in other compensation.
Stephen Mahoney, Chief Operating Officer, received a compensation package of $2.7M, which increased by 279% compared to previous year. 73% of the compensation package, or $2M, was in option awards.
John F. Paolini, Chief Medical Officer, earned $2.5M in 2018, a 221% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 17, 2019.